Lucid Genomics

Lucid Genomics is a Berlin-based health-tech company that leverages artificial intelligence to revolutionize the diagnosis of rare genetic diseases. A spin-off from the Max Planck Institute for Molecular Genetics, the company's platform specializes in identifying pathogenic structural variants and mutations within the non-coding regions of the human genome. By utilizing advanced machine learning algorithms, Lucid Genomics automates the interpretation of whole-genome sequencing data, providing clinicians with higher diagnostic yields than traditional methods. Their technology is designed to integrate seamlessly into clinical workflows, helping to end the diagnostic odyssey for patients with complex conditions. The company focuses on the dark matter of the genome to unlock personalized medicine opportunities for underserved patient populations.